Private equity firms have moved aggressively into the healthcare industry's more hidden niches: They are pouring billions into the business of clinical drug trials.
In a social media landscape shaped by hashtags, algorithms, and viral posts, nurse leaders must decide: Will they let the narrative spiral, or can they adapt and join the conversation?
...
